Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia
Leukemia
.
2017 May;31(5):1253-1254.
doi: 10.1038/leu.2017.14.
Authors
A M Eiring
,
B D G Page
,
I L Kraft
,
C C Mason
,
N A Vellore
,
D Resetca
,
M S Zabriskie
,
T Y Zhang
,
J S Khorashad
,
A J Engar
,
K R Reynolds
,
D J Anderson
,
A Senina
,
A D Pomicter
,
C C Arpin
,
S Ahmad
,
W L Heaton
,
S K Tantravahi
,
A Todic
,
R Colaguori
,
R Moriggl
,
D J Wilson
,
R Baron
,
T O'Hare
,
P T Gunning
,
M W Deininger
PMID:
28465516
DOI:
10.1038/leu.2017.14
No abstract available
Publication types
Published Erratum